Angel E. Garcı́a

Glan Clwyd Hospital — United Kingdom

Biochemistry, Genetics and Molecular Biology · Life Sciences

69h-index17.8kcitations343works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Protein Structure and Dynamics(148), Spectroscopy and Quantum Chemical Studies(71), Enzyme Structure and Function(62), DNA and Nucleic Acid Chemistry(44), RNA and protein synthesis mechanisms(41)

Publications343 total

Hydroxychloroquine in combination with platinum doublet chemotherapy as first-line treatment for extensive-stage small cell lung cancer (Study 15): A randomised phase II multicentre trial
European Journal of Cancer·2024· 3 citedOpen Access
Modeling DNA bubble formation at the atomic scale
OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)·2024· 1 citedOpen Access
Characterizing the Folding Transition-State Ensembles in the Energy Landscape of an RNA Tetraloop
Journal of Chemical Information and Modeling·2023· 12 citedOpen Access
Supplemental legend from Epithelial-to-Mesenchymal Transition Antagonizes Response to Targeted Therapies in Lung Cancer by Suppressing BIM
2023Open Access
Supplemental legend from Epithelial-to-Mesenchymal Transition Antagonizes Response to Targeted Therapies in Lung Cancer by Suppressing BIM
2023Open Access
SI Table 2 from Epithelial-to-Mesenchymal Transition Antagonizes Response to Targeted Therapies in Lung Cancer by Suppressing BIM
2023Open Access
SI Table 1 from Epithelial-to-Mesenchymal Transition Antagonizes Response to Targeted Therapies in Lung Cancer by Suppressing BIM
2023Open Access
SI Table 2 from Epithelial-to-Mesenchymal Transition Antagonizes Response to Targeted Therapies in Lung Cancer by Suppressing BIM
2023Open Access
Supplementary Figures 1-8 from Epithelial-to-Mesenchymal Transition Antagonizes Response to Targeted Therapies in Lung Cancer by Suppressing BIM
2023Open Access
Data from Epithelial-to-Mesenchymal Transition Antagonizes Response to Targeted Therapies in Lung Cancer by Suppressing BIM
2023Open Access
Supplementary Figures 1-8 from Epithelial-to-Mesenchymal Transition Antagonizes Response to Targeted Therapies in Lung Cancer by Suppressing BIM
2023Open Access
Data from Epithelial-to-Mesenchymal Transition Antagonizes Response to Targeted Therapies in Lung Cancer by Suppressing BIM
2023Open Access
SI Table 1 from Epithelial-to-Mesenchymal Transition Antagonizes Response to Targeted Therapies in Lung Cancer by Suppressing BIM
2023Open Access
Supplementary Figure 3 from ERM/ETV5 Up-regulation Plays a Role during Myometrial Infiltration through Matrix Metalloproteinase-2 Activation in Endometrial Cancer
2023Open Access
Data from ERM/ETV5 Up-regulation Plays a Role during Myometrial Infiltration through Matrix Metalloproteinase-2 Activation in Endometrial Cancer
2023Open Access
Supplementary Figure 1 from ERM/ETV5 Up-regulation Plays a Role during Myometrial Infiltration through Matrix Metalloproteinase-2 Activation in Endometrial Cancer
2023Open Access
Supplementary Figure 3 from ERM/ETV5 Up-regulation Plays a Role during Myometrial Infiltration through Matrix Metalloproteinase-2 Activation in Endometrial Cancer
2023Open Access
Supplementary Figure Legends 1-3 from ERM/ETV5 Up-regulation Plays a Role during Myometrial Infiltration through Matrix Metalloproteinase-2 Activation in Endometrial Cancer
2023Open Access
Supplementary Figure 2 from ERM/ETV5 Up-regulation Plays a Role during Myometrial Infiltration through Matrix Metalloproteinase-2 Activation in Endometrial Cancer
2023Open Access
Supplementary Figure 1 from ERM/ETV5 Up-regulation Plays a Role during Myometrial Infiltration through Matrix Metalloproteinase-2 Activation in Endometrial Cancer
2023Open Access
page 1 of 18Next →

Frequent Co-authors

Gerhard Hummer(9), Lawrence R. Pratt(8), Shekhar Garde(7), Dietmar Paschek(7), José N. Onuchic(6), Hugh Nymeyer(6), Chunyu Wang(4), Deepak R. Canchi(4), Henry D. Herce(4), S. Gnanakaran(4), Michael E. Paulaitis(3), Fabio Sterpone(2), David J. Rosenman(2), Nikolaos G. Sgourakis(2), Julien Roche(2), Catherine A. Royer(2), Marie‐Claire Bellissent‐Funel(1), Ali Hassanali(1), Martina Havenith(1), Richard H. Henchman(1)